MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 55 filers reported holding MYOVANT SCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $159,350,827 | +50.1% | 5,910,639 | -0.0% | 2.12% | +38.8% |
Q3 2022 | $106,191,000 | +44.3% | 5,912,639 | -0.1% | 1.52% | +46.5% |
Q2 2022 | $73,581,000 | -5.7% | 5,919,639 | +1.0% | 1.04% | +14.8% |
Q1 2022 | $78,042,000 | -18.8% | 5,859,039 | -5.0% | 0.91% | -8.5% |
Q4 2021 | $96,052,000 | -25.8% | 6,169,039 | +6.9% | 0.99% | -24.7% |
Q3 2021 | $129,458,000 | +7.9% | 5,769,039 | +9.5% | 1.31% | +12.2% |
Q2 2021 | $119,976,000 | +12.2% | 5,269,039 | +1.4% | 1.17% | +3.5% |
Q1 2021 | $106,893,000 | -19.4% | 5,194,039 | +8.1% | 1.13% | -25.6% |
Q4 2020 | $132,687,000 | +85.5% | 4,804,039 | -5.7% | 1.52% | +53.7% |
Q3 2020 | $71,542,000 | -25.3% | 5,092,000 | +9.6% | 0.99% | -27.1% |
Q2 2020 | $95,821,000 | +163.6% | 4,647,000 | -3.5% | 1.36% | +92.3% |
Q1 2020 | $36,354,000 | -51.4% | 4,815,109 | 0.0% | 0.70% | -40.5% |
Q4 2019 | $74,730,000 | +198.5% | 4,815,109 | 0.0% | 1.18% | +154.3% |
Q3 2019 | $25,039,000 | -29.2% | 4,815,109 | +23.1% | 0.47% | -22.8% |
Q2 2019 | $35,386,000 | – | 3,910,109 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
Matisse Capital | 32,750 | $508,000 | 0.36% |
VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |